KJKyoungwon Jung

Kyoungwon Jung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kyoungwon Jung has a total of 163 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial

    by Myeongseok Koh, Cheol Woong Choi, Dae Gon Ryu, Seung Jung Yu, Sung Eun Kim, Kyoungwon Jung, Bong Eun Lee, Moon Won Lee, Dong Chan Joo, Jin Lee, et al.

    Myeongseok Koh, Cheol Woong Choi, Dae Gon Ryu, Seung Jung Yu, Sung Eun Kim, Kyoungwon Jung, Bong Eun Lee, Moon Won Lee, Dong Chan Joo, Jin Lee, Ra Ri Cha, Sam Ryong Jee. Gut and Liver 2026;20:756-64. https://doi.org/10.5009/gnl250435

  • Open Access

    Bowel preparation for colonoscopy in special populations: a practical and risk-stratified approach

    by Myung-Hun Lee, Won Moon, Kyoungwon Jung, Jae Hyun Kim, Sung Eun Kim, Moo In Park, Seun Ja Park

    Bowel preparation is a key determinant of colonoscopy quality; however, inadequate cleansing remains common among patients with overlapping clinical and logistical barriers. In routine practice, preparation failure may prolong procedures, reduce diagnostic confidence, and necessitate early repeat colonoscopy. We review major society guidelines and selected studies addressing bowel preparation in inflammatory bowel disease (IBD), chronic kidney disease (CKD), older adults, chronic constipation, and hospitalized patients. Across these settings, the most consistently supported measures include split-dose administration, completion of the final dose close to the time of colonoscopy in accordance with local fasting and sedation policies, and structured patient instructions reinforced through follow-up communication. A standardized assessment of preparation quality is recommended to support quality improvement and appropriate follow-up. Risk stratification can help identify patients who may benefit from intensified preparation pathways, including those with prior inadequate preparation, severe constipation, frailty, or inpatient status. Safety considerations are particularly important in CKD, in which oral sodium phosphate should be avoided and magnesium-containing agents used cautiously; polyethylene glycol-based solutions are generally preferred. In IBD, regimen selection should also consider endoscopic interpretability because sodium phosphate preparations have been associated with preparation-related mucosal abnormalities that may confound the assessment of subtle inflammatory findings. Among hospitalized patients, system-level barriers often predominate, and protocolized pathways may improve workflow and patient comfort while maintaining cleansing effectiveness. We propose a practical, risk-stratified approach to regimen selection, timing, rescue strategies, and safety monitoring that can be implemented in high-volume clinical practice.

  • Open Access

    Autoimmune Gastritis Associated With a Gastric Hyperplastic Polyp: Two Case Reports and Review of its Neoplastic Potential

    by Myung-Hun Lee, Sung Eun Kim, Moo In Park, Kyoungwon Jung

    Autoimmune gastritis (AIG) results in the loss of oxyntic glands, achlorhydria, and hypergastrinemia and frequently leads to the development of gastric hyperplastic polyps (GHPs). AIG is increasingly being recognized as a major contributor to corpus-dominant atrophy in East Asia. Despite its increasing prevalence, it is frequently underdiagnosed in clinical practice. Although GHPs are typically benign, AIG is associated with an elevated risk of gastric cancer, including neuroendocrine tumors. Herein, we report two cases in which GHPs detected during screening endoscopy led to AIG identification. Both of the patients were negative for Helicobacter pylori and tested positive for antiparietal cell antibodies. Histological examination confirmed oxyntic atrophy and hyperplastic polyps, without any evidence of dysplasia. These case reports have highlighted that GHPs may develop in the context of H. pylori-associated gastritis as well as from autoimmune causes, thus emphasizing the importance of recognizing and assessing AIG during endoscopic screening. The possibility of coexisting AIG should be considered in individuals with GHPs. Accordingly, clinicians are advised to evaluate AIG when GHPs are detected in a background of corpus-dominant atrophy, as delayed recognition may miss the opportunity to identify a precancerous risk.

  • Open Access

    Oral microbial alterations by smoking and metabolic factors in esophageal squamous cell carcinoma

    by Kyoungwon Jung, Minjae Joo, Kwangwoo Nam, Joon Hyun Cho, Young Sin Cho, Seungyoon Nam, Su Youn Nam

    Background: It is important to understand how clinical factors affect microbial profiles, but few studies have evaluated these associations in patients with esophageal squamous cell carcinoma (ESCC). This study aimed to analyze differences in the oral microbiome between patients with ESCC and healthy controls, with subgroup analyses stratified by clinical and metabolic factors. Methods: From December 2021 to May 2023, oral swab samples and clinical data were collected from participants at five tertiary medical centers. Clinical data included age, sex, body mass index (BMI), smoking history, metabolic profiles such as cholesterol, triglycerides (TG), low-density lipoprotein (LDL), and high-density lipoprotein, and endoscopic findings. Sequencing and taxa abundance analyses were performed to compare oral microbiota between patients with ESCC and controls. Subgroup analyses were conducted to explore the impact of clinical factors on microbial community composition and diversity. Results: No significant differences in α- or β-diversity were observed between ESCC patients (n=21) and controls (n=20). However, subgroup analyses revealed distinct microbial patterns. Haemophilus parainfluenzae was less abundant in younger and low-LDL ESCC patients compared to controls, while Veillonella dispar was more abundant in older and high-LDL ESCC patients. Streptococcus infantis was less abundant in ESCC patients under 65 years compared to controls, and in smoking patients compared to non-smoking patients. Conclusions: The oral microorganisms H. parainfluenzae, V. dispar, and S. infantis may serve as potential biomarkers influenced by metabolic factors in ESCC.


  • Open Access

    =?UTF-8?B?R2FzdHJpYyBjYW5jZXIgd2l0aCBseW1waG9pZCBzdHJvbWEgbWltaWNraW5nIGEgc3ViZXBpdGhlbGlhbCBsZXNpb24gYWZ0ZXIgYSAxMC15ZWFyIGRpc2Vhc2UtZnJlZSBpbnRlcnZhbDogYSBjYXNlIHJlcG9ydA==?=

    by Bang Ju Kim, Sung Eun Kim, Seun Ja Park, Moo In Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Myung Hun Lee, Jung Wook Lee, Kyung Won Seo, et al.

    Gastric cancer with lymphoid stroma mimicking a subepithelial lesion after a 10-year disease-free interval: a case report

  • Open Access

    Reflux Esophagitis

    by Kyoungwon Jung

    Reflux esophagitis is a significant clinical manifestation of gastroesophageal reflux disease (GERD), and its prevalence is increasing because of lifestyle changes and increasing obesity. The diagnosis of GERD primarily emphasizes symptom-based approaches that focus on heartburn and acid regurgitation. GERD can be confirmed through proton pump inhibitor (PPI) therapy, endoscopy, and 24-hour impedance-pH monitoring. Of these methods, endoscopy plays a critical role in diagnosing reflux esophagitis. Recently, both PPIs and potassium-competitive acid blockers (P-CABs) have been recommended as first-line treatments, with P-CABs showing greater efficacy in severe cases or in patients unresponsive to PPIs. This review discusses the prevalence and risk factors of reflux esophagitis, presents the latest insights into its pathophysiology and diagnosis, and provides a comparative analysis of recent domestic and international guidelines.


  • Open Access

    Endoscopic diagnosis of Helicobacter pylori infection

    by Eun Jeong Gong, Kyoungwon Jung

    Accurate prediction of Helicobacter pylori infection status based on endoscopic findings is essential for optimizing management. This review emphasizes the importance of accurate endoscopic diagnosis of H. pylori infection. The endoscopic findings categorized in the Kyoto classification provide valuable indicators of infection status. Specifically, findings such as atrophic gastritis, intestinal metaplasia, nodular gastritis, enlarged folds, sticky mucus, xanthoma, and map-like redness are associated with H. pylori infection. Regular arrangement of collecting venules and linear red streaks are reliable indicators of non-infection. Selective testing based on endoscopic findings can optimize diagnosis and treatment of H. pylori infection and, minimizing unnecessary procedures. However, some findings overlap and do not clearly distinguish between current and past infections, indicating a need for further research.


  • Open Access

    Rapidly Growing Gastrointestinal Stromal Tumor on the Esophagus

    by Ji Hye Park, Sung Eun Kim, Seun Ja Park, Moo In Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Myung Hun Lee

    Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms that mainly occur in the stomach and small intestine; those arising in the esophagus are rarer. A 54-year-old woman was referred to our hospital with a one-month history of dysphagia. Esophagogastroduodenoscopy (EGD), performed approximately five months earlier, had not revealed any specific findings. However, an EGD performed in our hospital showed the presence of a round, protruding lesion (approximately 40×30 mm in size), with a normal overlying mucosal surface, 35–39 cm from the upper incisor. Chest computed tomography (CT) revealed a large esophageal mass. Enucleation was performed on the esophageal mass, and a GIST was diagnosed using immunochemical staining. Imatinib mesylate administration was initiated two months postoperatively. The patient was stable, without any evident recurrence in the 8-month postoperative follow-up EGD and chest CT examinations. Therefore, physicians should consider that patients with worsening dysphagia may have an underlying organic condition, such as an acute increase in size of an esophageal GIST, even if recent examinations were unremarkable.


  • Open Access

    Long-Term Outcomes and Risk Factors for Lymph Node Metastasis in Siewert Type II/III Early Gastric Cancer

    by Min Young Son, Dae Hyeon Cho, Sung Eun Kim, Seun Ja Park, Moo In Park, Won Moon, Jae Hyun Kim, Jung Wook Lee, Kyoungwon Jung

    Objectives: The incidence of adenocarcinomas of the esophagogastric junction (EGJ) and cardia has been gradually increasing in the East. Cancers of the EGJ and gastric cardia have poor prognoses. This study aimed to investigate lymph node metastasis (LNM) rates, their predictive factors, and determine the long-term outcomes of patients with Siewert type II/III early gastric cancer (EGC).Methods: Between January 2014 and June 2022, a total of 573 patients with gastric cancer, including 130 with Siewert type II/III EGC, underwent total gastrectomies at the Kosin University Gospel Hospital. Factors associated with LNM were analyzed using a logistic regression model.Results: Of the 130 patients with Siewert type II/III EGC, 10 (7.7%) demonstrated LNM (LNM-positive group). Macroscopically elevated lesions (I+IIa) (60.0% vs. 16.7%; p=0.009) and lymphovascular invasion (70.0% vs. 5.8%; p<0.001) were more common and the depth of invasion was deeper (p=0.003) in the LNM-positive patients than in the LNMnegative group. Multivariate analysis showed that macroscopically elevated lesions (odds ratio [OR], 19.48; 95% confidence interval [CI], 1.93–197.11; p=0.012) and lymphovascular invasion (OR, 52.63; 95% CI, 5.26–526.51; p=0.001) were associated with LNM. Kaplan–Meier analysis revealed that the 5-year overall and disease-specific survival rates of patients with Siewert type II/III EGC were 90.0% and 98.9%, respectively. During a median follow-up period of 49 months (range, 12–122 months), one patient (0.8%) died owing to gastric cancer recurrence.Conclusions: Patients with Siewert type II/III EGC showed favorable long-term outcomes. Macroscopically elevated lesions and lymphovascular invasion are associated with LNM.


  • Open Access

    Immunotherapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma

    by Sung Eun Kim, Kyoungwon Jung, Moo In Park

    Sung Eun Kim, Kyoungwon Jung, Moo In Park. Journal of Digestive Cancer Research 2024;12:72-81. https://doi.org/10.52927/jdcr.2024.12.2.72